"Courtesy" Letter Process Under Review At FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to revisit its use of "courtesy" letters to respond to inappropriate dietary supplement claims, Center for Food Safety & Applied Nutrition's Robert Moore, PhD, said at a joint CRN/CHPA briefing in Washington, D.C. Feb. 16.